Chadwick lab:Publications: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
mNo edit summary
mNo edit summary
Line 5: Line 5:
<ol type="1">
<ol type="1">


<li> [http://pubs.acs.org/doi/abs/10.1021/cg2010858?prevSearch=%255BContrib%253A%2BChadwick%2BK%255D%2Band%2B%255BContrib%253A%2BChadwick%252C%2BKeith%255D&searchHistoryKey= Towards the Rational Design of Crystalline Surfaces for Heteroepitaxy: The Role of Molecular Functionality.] Chadwick K., Chen J., Myerson A.S., and Trout B.L.; Crystal Growth & Design 12 (2012): 1159-1166.</li>
<li> [http://pubs.acs.org/doi/abs/10.1021/cg2010858?prevSearch=%255BContrib%253A%2BChadwick%2BK%255D%2Band%2B%255BContrib%253A%2BChadwick%252C%2BKeith%255D&searchHistoryKey= Towards the Rational Design of Crystalline Surfaces for Heteroepitaxy: The Role of Molecular Functionality.] Chadwick K., Chen J., Myerson A.S., and Trout B.L.; <em>Crystal Growth & Design</em> 12 (2012): 1159-1166.</li>


<li> [http://pubs.rsc.org/en/content/articlelanding/2012/ce/c1ce06358h#divAbstract Separation of Impurities from Active Pharmaceutical Ingredients by Selective Co-Crystal Formation.] Hsi, K., Chadwick, K., Fried A., Kenny, M., and Myerson, A. S.; CrystEngComm 14 (2012): 2386-2388.</li>
<li> [http://pubs.rsc.org/en/content/articlelanding/2012/ce/c1ce06358h#divAbstract Separation of Impurities from Active Pharmaceutical Ingredients by Selective Co-Crystal Formation.] Hsi, K., Chadwick, K., Fried A., Kenny, M., and Myerson, A. S.; <em>CrystEngComm</em> 14 (2012): 2386-2388.</li>


<li></li>
<li></li>

Revision as of 08:52, 25 November 2013

Home        Research        Contact        Internal        Lab Members        Publications        Talks       

Recent Publications

  1. Towards the Rational Design of Crystalline Surfaces for Heteroepitaxy: The Role of Molecular Functionality. Chadwick K., Chen J., Myerson A.S., and Trout B.L.; Crystal Growth & Design 12 (2012): 1159-1166.
  2. Separation of Impurities from Active Pharmaceutical Ingredients by Selective Co-Crystal Formation. Hsi, K., Chadwick, K., Fried A., Kenny, M., and Myerson, A. S.; CrystEngComm 14 (2012): 2386-2388.

Book Chapters

Invited Chapter:


Edited Textbook Chapters



Refereed Abstracts


Posters

Separation of Impurities from Active Pharmaceutical Ingredients by Selective Co-Crystal Formation; Hsi, K., Chadwick, K., Fried A., Kenny, M., and Myerson, A. S.; CrystEngComm 14 (2012): 2386-2388.

The Crystallization and Characterization of Composite Spherical Particles; Quon J. L., Chadwick K., Myerson A. S., Hatton T. A., Trout B. L.; manuscript being prepared for submission to Organic Process Research and Development (2012).

The Effect of Substrate Surface Morphology on the Nucleation Kinetics of Acetaminophen; Quon J. L., Chadwick K., Sheu I., Brettmann B. K., Myerson A. S., Trout B. L.; manuscript being prepared for submission to Crystal Growth and Design (2012).

Self Promoted Heterogeneous Nucleation: Crystallization Controlled by Cooperativity; Chadwick K., Wood G., Sheu I., Levina A., Myerson A. S., Trout B. L.; manuscript being prepared for submission to the Journal of the American Chemical Society (2012).

A novel thin film-based pharmaceutical tablet manufacturing process: formulation, processing, and properties; Du Y., Luna L. E., Chadwick K., Kim K. T., Xi L., Myerson A. S., Trout B. L.; manuscript submitted to Pharmaceutical Research (2012).

Making a Disappearing Polymorph Reappear: Controlling Polymorphism Using Crystalline Substrates; Chadwick K., Ma X., Myerson A. S., Trout B. L.; manuscript submitted to CrystEngComm (2012).

Polymorphic Control by Heterogeneous Nucleation – A New Method for Selecting Crystalline Substrates; Chadwick K., Myerson A. S., Trout B. L.; CrystEngComm 2011; 13; 6625-6627.

Solubility, metastable zone width measurement and crystal growth of the 1:1 benzoic acid/isonicotinamide cocrystal in solutions of variable stoichiometry; Boyd, S.; Back, K.; Chadwick, K.; Davey, R. J.; Seaton, C. C.; Journal of Pharmaceutical Science 2010; 99; 3779-3786.

Designing Acid/Acid Co-Crystals through the Application of Hammett Substituent Constants; Seaton, C. C.; Chadwick, K.; Sadiq, G.; Guo, K.; Davey, R. J.; Crystal Growth & Design 2010; 10; 726-733.

Designing Acid/Acid Co-Crystals - The Use of Hammett Substitution Constants; Chadwick, K.; Sadiq, G.; Davey, R. J.; Seaton, C. C.; Pritchard, R. G.; Parkin, A.; Crystal Growth & Design 2009; 9; 1278-1279.

Crystallization from Water-in-Oil Emulsions As a Route to Spherical Particulates: Glycine and the Hydrochloride Salts of Glutamic Acid and Ephedrine; Chadwick, K.; Davey, R. J.; Mughal, R.; Marziano, I.; From Organic Process Research & Development 2009; 13; 1284-1290.

The utility of a ternary phase diagram in the discovery of new co-crystal forms; Chadwick, K.; Davey, R.; Sadiq, G.; Cross, W.; Pritchard, R.; CrystEngComm 2009; 11; 412-414.

Cocrystallization: A Solution Chemistry Perspective and the Case of Benzophenone and Diphenylamine; Chadwick, K.; Davey, R. J.; Dent, G.; Pritchard, R. G.; Hunter, C. A.; Musumeci, D.; Crystal Growth & Design 2009; 9; 1990-1999.

How does grinding produce co-crystals? Insights from the case of benzophenone and diphenylamine; Chadwick, K.; Davey, R.; Cross, W.; CrystEngComm 2007; 9; 732-734.

<html>Hosted by <a href="http://www.openwetware.org"><img src="http://openwetware.org/images/0/01/80x15_openwetware.png" border="0" /></a></right> </html>